Russian President Vladimir Putin discussed the drug market in the country with members of the government. He noted that despite the growth of pharmaceutical production in the country, there was a shortage of some medicines. The cost of medicines has also increased.
“The fact is that, firstly, our prices have grown lately. And there was a certain deficit for some medicines, despite the fact that we have an increase in production, pharmaceutical products for the three quarters of last year, it amounted to about 22%,” the president said.
During the meeting, Vladimir Putin also recalled that Russia did not impose restrictions on the import of medicines for foreign companies, and foreign manufacturers continue to work on the Russian market. At the same time, the president noted the importance of building up own research in the pharmaceutical industry.
“As you know, we do not prohibit imports, we do not restrict them. We work with manufacturers who traditionally work in our market, foreign manufacturers. I must say that many continue this work as usual. But some of them have suspended research, as we see. And, of course, it is very important here to step up our efforts in this area,” Mr. Putin said.
Minister of Health of Russia Mikhail Murashko, speaking with a report, stressed the need to support the promotion of domestic drugs, as well as explain to the population that they are not inferior in quality to foreign drugs. According to him, about 6 billion packages of medicines are introduced to the Russian market during the year, about 70% of which are domestic drugs.
Formerly Ministry of Health turned on iodine and aspirin on the list of potentially scarce drugs. A total of 97 positions were included in the list.
In 2022, public procurement operators purchased medicines for 910 billion rubles, which is 5% more year-on-year. Purchases for district hospitals decreased by 32%, for city hospitals - by 28%. Kommersant's interlocutors attribute the situation not only to a decrease in the incidence of COVID-19, but also to saving money against the backdrop of hostilities in Ukraine.
More details - in the publication "Kommersant" "Reduction for hospital purposes".